Coated plant virus imaging agents

US10207014B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10207014-B2
Application numberUS-201815937681-A
CountryUS
Kind codeB2
Filing dateMar 27, 2018
Priority dateAug 5, 2014
Publication dateFeb 19, 2019
Grant dateFeb 19, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An imaging nanoparticle comprising a plant virus particle having an interior surface and an exterior surface, an imaging agent that is linked to the interior and/or exterior surface, and a layer of biocompatible mineral such as silica coated over the exterior surface, is described. The imaging nanoparticle can be used in method of generating an image of a tissue region of a subject, by administering to the subject a diagnostically effective amount of an imaging nanoparticle and generating an image of the tissue region of the subject to which the imaging nanoparticle has been distributed.

First claim

Opening claim text (preview).

What is claimed is: 1. A spherical imaging nanoparticle, comprising a spherical arrangement of a plurality of rod-shaped plant virus particles, each rod-shaped plant particle having an interior surface, and an imaging agent that is linked to the interior surface, and a biocompatible mineral coating on an exterior surface of the spherical arrangement of rod-shaped plant virus particles. 2. The imaging nanoparticle of claim 1 , wherein the biocompatible mineral is silica. 3. The imaging nanoparticle of claim 1 , wherein the spherical arrangement is formed from coat proteins of the rod-shaped virus particles. 4. The imaging nanoparticle of claim 3 , wherein the rod-shaped virus particles belong to the Virgaviridae family. 5. The imaging nanoparticle of claim 3 , wherein the rod-shaped virus particles are tobacco mosaic virus particles. 6. The imaging nanoparticle of claim 1 , wherein the imaging agent is a magnetic resonance imaging agent. 7. The imaging nanoparticle of claim 6 , wherein the imaging agent is a chelated lanthanide. 8. The imaging nanoparticle of claim 7 , wherein the lanthanide is gadolinium. 9. The imaging nanoparticle of claim 8 , wherein the plant virus particles are selected from the group consisting of iGd-TMV-Si, eGd-TMV, eGd-TMV-Si, Gd-SNP, and Gd-SNP-Si, and wherein the plant virus particles have a relaxivity of greater than about 25,000 mM −1 S −1 per particle. 10. The imaging nanoparticle of claim 1 , wherein a targeting moiety is linked to the exterior surface of the virus particle. 11. The imaging nanoparticle of claim 1 , wherein at least about 500 imaging agent molecules are linked to the virus particle. 12. The spherical imaging nanoparticle of claim 1 , the spherical arrangement of a plurality of rod-shaped plant virus particles is formed from about 10 to about 50 rod-shaped virus particles. 13. A method of generating an image of a tissue region of a subject, the method comprising administering to the subject a diagnostically effective amount of an imaging nanoparticle, comprising a spherical arrangement of a plurality of rod-shaped plant virus particles, each rod-shaped plant virus particle having an interior surface and an imaging agent that is linked to the interior surface, and a layer of biocompatible mineral coating an exterior surface of the spherical arrangement of rod-shaped plant virus particles, and generating an image of the tissue region of the subject to which the imaging nanoparticle has been distributed. 14. The method of claim 13 , wherein the biocompatible mineral is silica. 15. The method of claim 13 , wherein the spherical plant virus is formed from coat proteins of a rod-shaped virus particles. 16. The method of claim 15 , wherein the rod shaped virus particles are tobacco mosaic virus particles. 17. The method of claim 13 , wherein the method of generating an image is magnetic resonance imaging, and the imaging agent is a chelated lanthanide. 18. The method of claim 13 , wherein the imaging nanoparticle further comprises a targeting moiety is linked to the exterior surface of the virus particle. 19. The method of claim 13 , the spherical arrangement of a plurality of rod-shaped plant virus particles is formed from about 10 to about 50 rod-shaped virus particles.

Assignees

Inventors

Classifications

  • the metal complex being Gd-DOTA · CPC title

  • conjugated systems · CPC title

  • not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10207014B2 cover?
An imaging nanoparticle comprising a plant virus particle having an interior surface and an exterior surface, an imaging agent that is linked to the interior and/or exterior surface, and a layer of biocompatible mineral such as silica coated over the exterior surface, is described. The imaging nanoparticle can be used in method of generating an image of a tissue region of a subject, by administ…
Who is the assignee on this patent?
Case Wester Reserve Univ, Univ Case Western Reserve
What technology area does this patent fall under?
Primary CPC classification A61K49/1896. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).